Nikravangolsefid N - Search Results

1

Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.

GBD 2021 Forecasting Collaborators. GBD 2021 Forecasting Collaborators. Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8. Lancet. 2024. PMID: 38762325 Free PMC article.

2

Development and validation of a preliminary multivariable diagnostic model for identifying unusual infections in hospitalized patients.

Tekin A, Joghataee M, Rovati L, Truong H, Castillo-Zambrano C, Kushagra K, Nikravangolsefid N, Ozkan M, Gupta A, Herasevich V, Domecq J, O'Horo J, Gajic O. Tekin A, et al. Among authors: nikravangolsefid n. Biomol Biomed. 2024 Apr 20. doi: 10.17305/bb.2024.10447. Online ahead of print. Biomol Biomed. 2024. PMID: 38643478 Free article.

3

Temporal Relationship and Clinical Outcomes of Acute Kidney Injury Following Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.

Charkviani M, Truong HH, Nikravangolsefid N, Ninan J, Prokop LJ, Reddy S, Kashani KB, Domecq Garces JP. Charkviani M, et al. Among authors: nikravangolsefid n. Crit Care Explor. 2024 Feb 12;6(2):e1054. doi: 10.1097/CCE.0000000000001054. eCollection 2024 Feb. Crit Care Explor. 2024. PMID: 38352941 Free PMC article. Review.

4

Acetazolamide for acute kidney injury in patients undergoing high dose methotrexate therapy: a systematic review and meta-analysis.

Truong HH, Reddy S, Charkviani M, Nikravangolsefid N, Ninan J, Hassett L, Kashani KB, Domecq JP. Truong HH, et al. Among authors: nikravangolsefid n. J Nephrol. 2024 Jan 24. doi: 10.1007/s40620-023-01850-2. Online ahead of print. J Nephrol. 2024. PMID: 38265601 Review.

5

Restrictive versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI): a pilot clinical trial protocol.

Murugan R, Chang CH, Raza M, Nikravangolsefid N, Huang DT, Palevsky PM, Kashani K; (RELIEVE-AKI) Study Investigators. Murugan R, et al. Among authors: nikravangolsefid n. BMJ Open. 2023 Jul 7;13(7):e075960. doi: 10.1136/bmjopen-2023-075960. BMJ Open. 2023. PMID: 37419639 Free PMC article.

6

The role of medicinal products in the treatment of inflammatory bowel diseases (IBD) through inhibition of TLR4/NF-kappaB pathway.

Dejban P, Nikravangolsefid N, Chamanara M, Dehpour A, Rashidian A. Dejban P, et al. Among authors: nikravangolsefid n. Phytother Res. 2021 Feb;35(2):835-845. doi: 10.1002/ptr.6866. Epub 2020 Sep 14. Phytother Res. 2021. PMID: 32929778 Review.

7

COVID-19 and Gynecomastia: What is the Relationship?

Kazemi MA, Hemmati S, Moradi B, Sharifian H, Firooznia K, Nikravangolsefid N. Kazemi MA, et al. Among authors: nikravangolsefid n. Acad Radiol. 2020 Aug;27(8):1188. doi: 10.1016/j.acra.2020.05.003. Epub 2020 May 11. Acad Radiol. 2020. PMID: 32418781 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7 results

Search Page